OTCM
MDXHF
Market cap10mUSD
Oct 24, Last price
0.04USD
Name
Medx Health Corp
Chart & performance
P/E
—
P/S
34.10
EPS
—
Vol. 1Y
—
Shs. 5Y
12.22%
Rev. 5Y
-2.26%
Div Yld LY
—
Div Yld TTM
—
Revenues
473k
-3.43%
Net income
-6m
L+72.06%
CFO
-4m
L+48.44%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
MedX Health Corp. develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It offers SIAscopy on DermSecure telemedicine platform, which is used to scan skin for suspicious moles and lesions, and phototherapeutic medical devices. Its brands include the DermSecure, MoleMate, SIMSYS, and SIAMETRICS. The company was founded on April 15, 1999 and is headquartered in Mississauga, Canada.
Key people
Stephen Lockyer
President, Acting Chief Executive Officer, Director · since 2023
Independent Vice Chairman of the Board · since 2023
Lesley Bourget
Chief Financial Officer · since 2021
Michael Druhan
President - Dermatological Services and Products · since 2020
Christopher Freeman
Acting Chief Financial Officer, Secretary · since 2022
Edmund Ho
Independent Director · since 2023
Kenneth McKay
Independent Chairman of the Board · since 2021
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||